Prospera Financial Services’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,088
Closed -$10K 2685
2022
Q1
$10K Buy
+1,088
New +$9.72K ﹤0.01% 2053
2020
Q4
Sell
-1,088
Closed -$15K 1622
2020
Q3
$15K Buy
+1,088
New +$16.3K 0.01% 993
2017
Q2
Sell
-1,089
Closed -$236K 460
2017
Q1
$236K Sell
1,089
-44
-4% -$6.29K 0.04% 310
2016
Q4
$105K Hold
1,133
0.02% 376
2016
Q3
$153K Hold
1,133
0.03% 361
2016
Q2
$115K Hold
1,133
0.02% 337
2016
Q1
$186K Buy
1,133
+44
+4% +$8.92K 0.04% 306
2015
Q4
$357K Hold
1,089
0.08% 174
2015
Q3
$351K Sell
1,089
-22
-2% -$9.66K 0.09% 163
2015
Q2
$443K Sell
1,111
-667
-38% -$283K 0.11% 144
2015
Q1
$875K Sell
1,778
-555
-24% -$215K 0.19% 74
2014
Q4
$835K Sell
2,333
-556
-19% -$165K 0.21% 75
2014
Q3
$557K Hold
2,889
0.15% 113
2014
Q2
$690K Hold
2,889
0.19% 87
2014
Q1
$738K Sell
2,889
-444
-13% -$136K 0.23% 61
2013
Q4
$660K Sell
3,333
-1,203
-27% -$214K 0.22% 73
2013
Q3
$838K Hold
4,536
0.32% 68
2013
Q2
$823K Buy
+4,536
New +$642K 0.38% 67

Other funds holding LUMO

Prospera Financial Services's LUMO Position: Q2 2022 in Review

Prospera Financial Services sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2022, closing a stake of 1,088 shares — an estimated $10K sold.

Prospera Financial Services first reported a position in LUMO in Q2 2013 and held it in 18 quarters. The position peaked at $875K in Q1 2015. 36 funds tracked by Wall St. Rank hold LUMO as of Q2 2022.

  • Prospera Financial Services reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 1,088 Lumos Pharma, Inc. Common Stock shares in Q2 2022, an estimated $10K.
  • Prospera Financial Services first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 18 quarters.
  • Prospera Financial Services's Lumos Pharma, Inc. Common Stock position peaked at $875K in Q1 2015.
  • 36 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.